Product
Bordetella pertussis D420
1 clinical trial
1 indication
Indication
PertussisClinical trial
Open-label, Phase 1, Dose-escalation Clinical Trial to Establish a Controlled Human Infection Model by Determining the Optimal and Safe Bordetella Pertussis Dose That Induces Mild Symptomatic Infection and Colonization in Healthy AdultsStatus: Recruiting, Estimated PCD: 2024-01-01